SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-24-013289
Filing Date
2024-03-27
Accepted
2024-03-27 16:02:08
Documents
14
Effectiveness Date
2024-03-27

Document Format Files

Seq Description Document Type Size
1 S-8 crdfs-8032724.htm S-8 118662
2 EX-FILING FEES a107ex.htm EX-FILING FEES 17158
3 EX-5.1 a51ex.htm EX-5.1 9842
4 EX-23.2 a232ex.htm EX-23.2 2110
5 EX-99.1 a991ex.htm EX-99.1 13754
6 EX-99.2 a992ex.htm EX-99.2 13577
7 EX-99.3 a993ex.htm EX-99.3 13576
8 EX-99.4 a994ex.htm EX-99.4 13571
9 EX-99.5 a995ex.htm EX-99.5 13580
10 EX-99.6 a996ex.htm EX-99.6 13591
11 EX-99.7 a997ex.htm EX-99.7 13562
12 EX-99.8 a998ex.htm EX-99.8 13592
13 image_0a.jpg GRAPHIC 280
14 image_1a.jpg GRAPHIC 280
  Complete submission text file 0001628280-24-013289.txt   258883
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278266 | Film No.: 24790518
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)